Dr. Inamul Haque

Inamul Haque was born at Supaul Bazar in Darbhanga (India). Dr. Haque received his BSc, MSc and B. Ed in Biosciences from Jamia Millia Islamia, a Central University in New Delhi. He received a Ph. D under the supervision of Professor Faizan Ahmad, a great protein chemist. He then moved to USA to join Dr. Mark T. Fisher’s lab at University of Kansas Medical Center, Kansas City, Kansas, USA. Currently, Dr. Haque is a Research Scientist at VA Medical Center, Kansas City, and has a joint appointment as an Assistant Professor in the University of Kansas Medical Center. He did ground breaking research in the regulation and function of two of CCN family members, i.e., CCN1 and CCN5 in mediating epithelial to Mesenchymal transition and SHh signaling. An additional area of research in his lab is focused on the role of microRNAs (small non-coding RNAs) in the regulation of invasive phenotypes in breast as well as in pancreatic cancer. Recently, he is involved in the drug development in NLRP3 inflammasome inhibitor. He is serving as an adjunct professor in the the Kansas City Kansas Community College where he is teaching Human anatomy & Physiology and Microbiology. He is the Topical Advisory Panel Member of journal IJMS in MDPI.